Efficacy and safety of NT 201 for upper limb spasticity of various etiologies--a randomized parallel-group study.

@article{Barnes2010EfficacyAS,
  title={Efficacy and safety of NT 201 for upper limb spasticity of various etiologies--a randomized parallel-group study.},
  author={Michael Philip Barnes and Alexis Schnitzler and L{\'e}lia Bristo de Medeiros and Monica Aguilar and Andrea Lehnert-Batar and Petra Minnasch},
  journal={Acta neurologica Scandinavica},
  year={2010},
  volume={122 4},
  pages={295-302}
}
OBJECTIVE To assess efficacy and safety of two dilutions of botulinum neurotoxin type A NT 201 (Xeomin®) in patients with upper limb spasticity of diverse etiology. METHODS Changes in functional disability and muscle tone from baseline to week 4 after NT 201 treatment. RESULTS One hundred ninety-two patients with stroke, brain injury, multiple sclerosis, or cerebral palsy were randomized to either 50 or 20 U/ml NT 201 dilutions. The maximum total NT 201 dose was 495 units. Four weeks post… CONTINUE READING
19 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…